MMS Named Finalist in Citeline’s 2025 Scrip Awards for Best Contract Research Organization (CRO) – Read More
January 13th, 2026
Making Clinical Trial Technology Work in Practice
December 17th, 2025
Advance Psychedelic Drug Development With Proven Regulatory and Data Expertise
Agile Medical Writing Staff Augmentation When You Need Expertise Not Headcount
Biometrics Solutions Fact Sheet: End-to-End Data Expertise for Complex Clinical Trials
Estimands: Opportunity or Risk for Drug Developers?
December 16th, 2025
Inside Pharma and Biotech’s Shifting Landscape and the Direction Leaders Are Giving for 2026
January 29th, 2026
Technology Use Cases: Shaping the Future of Trial Design and Implementation
December 10th, 2025
From Challenge to Confidence: How MMS Delivered 800+ High-Quality Narratives in Record Time
December 9th, 2025
The Real Meaning of “Expedited” in Drug Development
December 4th, 2025
Former FDA, CRO, and Industry Leader Dr. Stephine Keeton Joins MMS as Senior Director of Biometrics
How MMS Modernized Pulmonary Data Models to Streamline Clinical Analysis and Improve Decision-Making
December 2nd, 2025
What AI Singularity Could Mean for the Future of Clinical Biometrics